top of page


March 2024

Truly Co-Founders Present at RESI Conference


Truly co-founders Sam & Abe pitched to judges and investors at the 2024 Redefining Early Stage Investments (RESI) South Conference in Atlanta, Georgia.

Nov 2023

Featured in 2023 Tuberculosis Diagnostics Pipeline Report


Truly's OsmoProcessor technology was featured in the 2023 Tuberculosis Diagnostics Pipeline report

DCN ALFC_edited.jpg
Feb 2024

DCN Advanced Lateral Flow Conference (ALFC)


Truly Team attends DNC's Advanced Lateral Flow Conference in San Diego, CA, USA to meet potential lateral flow development partner manufacturers. 

July 2023

Biomaterials International 2023 Conference


Truly Co-Founders Present at the Biomaterials International 2023 Conference in Sapporo, Japan

July 2023
Summer 2023 Intern Cover.png

Summer 2023 Interns


Truly is thrilled to welcome Alex, Mateo and Maryam as 2023 Summer Interns! 

sbir logo.png
May 2023

SBIR Phase I Funding


Truly Technologies LLC receives $270K Phase I SBIR funding from the National Institute of Allergies and Infectious Diseases (NIAID).

October 2022

UW CoMotion Innovation Showcase


Osmotic sample processor wins lightning round at CoMotion Innovation Showcase.

Patent Figure.png
August 2022

Patent Filed


Inventors file PCT patent WO2023019109A1 - "Fluid Sample Concentrator."

June 2022

UW CoMotion STEP Fund


Osmotic sample processor receives $25,000 UW CoMotion STEP Fund.

June 2022

Osmotic Processor Manuscript Published

Osmotic Processor for Enabling Sensitive and Rapid Biomarker Detection via Lateral Flow Assays was published in Frontiers in Bioengineering and Biotechnology.

May 2022

Population Health Recognition Award 

Osmotic Processor for Enabling Sensitive and Rapid Biomarker Detection via Lateral Flow Assays wins Population Health Recognition Award at the 2022 UW Undergraduate Research Symposium.

February 2022

Truly Technologies LLC 


OsmoProcessor LLC is now Truly Technologies, LLC.

July 2021
NSP I-Corps.png

OsmoProcessor Completes NSF I-Corps Program

The OsmoProcessor team completed the National Science Foundation (NSF) I-Corps program supported by UW CoMotion and the Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH), and received $2500 of customer discovery funding.

June 2021

OsmoProcessor, LLC Company Formation


OsmoProcessor, LLC was formed in Seattle, Washington, USA.

lemelson logo.png
April 2021

"Cure it!" Lemelson-MIT Student Prize Finalist

OsmoProcessor was selected as a finalist in the 2021 Lemelson-MIT Student Prize.

March 2021

Hollomon Health Innovation Challenge - Best Idea Prize

Team OsmoProcessor wins the Cambia Grove Best Idea for Addressing Health Access and Disparities Prize at UW Buerk Center of Entrepreneurship Hollomon Health Innovation Challenge.

January 2021

Royalty Research Fund

Proposal "A simple rapid method of concentrating urine for tuberculosis diagnosis" was awarded $40,000 UW Royalty Research Fund.

August 2022

NIBIB & VentureWell DEBUT Challenge - 2nd Place

Team OsmoProcessor wins 2nd Place at 2020 NIBIB & VentureWell Design by Biomedical Undergraduate Teams (DEBUT) Challenge.

bottom of page